Stocks and Investing
Stocks and Investing
Fri, February 12, 2021
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
[ Fri, Feb 12th 2021
] - WOPRAI
Gena Wang Maintained (ALNY) at Buy with Increased Target to $196 on, Feb 12th, 2021
Gena Wang of Barclays, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $162 to $196 on, Feb 12th, 2021.
Gena has made no other calls on ALNY in the last 4 months.
There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, all agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Do Kim of "BMO Capital" Downgraded from Buy to Hold and Held Target at $185 on, Monday, January 25th, 2021
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $93 on, Wednesday, November 25th, 2020
Contributing Sources